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Abstract
Background: Various robotic technologies have been developed recently for objective and quantitative assessment
of movement. Among them, robotic measures derived from a reaching task in the KINARM Exoskeleton device are
characterized by their potential to reveal underlying motor control in reaching movements. The aim of this study
was to examine the clinical usefulness and validity of these robot-derived measures in hemiparetic stroke patients.
Methods: Fifty-six participants with a hemiparetic arm due to chronic stroke were enrolled. The robotic assessment
was performed using the Visually Guided Reaching (VGR) task in the KINARM Exoskeleton, which allows free arm
movements in the horizontal plane. Twelve parameters were derived based on motor control theory. The following
clinical assessments were also administered: the proximal upper limb section in the Fugl-Meyer Assessment
(FMA-UE(A)), the proximal upper limb part in the Stroke Impairment Assessment Set (SIAS-KM), the Modified
Ashworth Scale for the affected elbow flexor muscles (MAS elbow), and seven proximal upper limb tasks in the
Wolf Motor Function Test (WMFT). To explore which robotic measures represent deficits of motor control in the
affected arm, the VGR parameters in the paretic arm were compared with those in the non-paretic arm using the
Wilcoxon signed rank test. Then, to explore which VGR parameters were related to overall motor control
regardless of the paresis, correlations between the paretic and non-paretic arms were examined. Finally, to
investigate the relationships between the robotic measures and the clinical scales, correlations between the VGR
parameters and clinical scales were investigated. Spearman’s rank correlation coefficients were used for all
correlational analyses.
Results: Eleven VGR parameters on the paretic side were significantly different from those on the non-paretic
side with large effect sizes (|effect size| = 0.76–0.87). Ten VGR parameters correlated significantly with FMA-UE(A)
(|r| = 0.32–0.60). Eight VGR parameters also showed significant correlations with SIAS-KM (|r| = 0.42–0.49), MAS
elbow (|r| = 0.44–0.48), and the Functional Ability Scale of the WMFT (|r| = 0.52–0.64).
Conclusions: The robot-derived measures could successfully differentiate between the paretic arm and the
non-paretic arm and were valid in comparison to the well-established clinical scales.
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Background
Reaching is an essential function for many activities of daily
living (ADL) such as feeding, toileting, grooming, and
dressing, but is commonly impaired in post-stroke patients.
It is therefore necessary for rehabilitation practitioners to
understand the details of normal and impaired reaching
movement. Reaching requires not only multiple-joint co-
ordination but also involvement of the central nervous
system (CNS) to plan strategies to control the musculoskel-
etal system. Because of its complexity and redundancy,
reaching movement is difficult to quantify in clinical prac-
tice [1]. In clinical settings, motor impairment after a
stroke is usually assessed with clinical scales specific to
CNS lesions such as the Brunnstrom Recovery Stages [2],
the Fugl-Meyer Assessment (FMA) [3], and the Chedoke-
McMaster Stroke Assessment (CMSA) [4], which were
developed based on the typical motor recovery patterns of
hemiparesis. On the other hand, the function of the
upper extremities can be assessed with various task-
based instruments such as the Action Research Arm
Test [5], the Box Block Test [6], and the Wolf Motor
Function Test (WMFT) [7]. Those tests score function
on a ‘can’ or ‘cannot’ basis or in terms of the time
required to complete a task. However, the relationship
between the reaching function itself and those well-
established assessments for impairment and/or function
is not fully understood. Furthermore, these clinically
used assessments cannot provide any information about
the underlying strategies and mechanisms of impaired
motor control in stroke patients.
Recently, various kinds of robotic technologies have
been developed for more accurate assessment of reach-
ing movement. Generally, robotic assessments can be
objective, quantitative, and continuous scales with less
floor or ceiling effects compared to conventional clin-
ical tools [8]. According to Balasubramanian et al. [9], cur-
rently existing movement measures used in rehabilitation
robotics are classified into three broad categories: kinematic
measures (e.g., movement deviation, time, and velocity),
kinetic measures (e.g., force direction error and amount of
assistance), and neuromechanical measures (e.g., arm
impedance). Several robots such as the RUPERT (Robotic
assisted UPper Extremity Repetitive Therapy) device [10],
MEMOS (MEchatronic system for MOtor recovery after
Stroke) [11], and the InMotion2 robot (Interactive Motion
Technologies, Inc.) [12]—which is a commercial version of
the MIT-Manus [13]—can provide multiple kinematic and
kinetic measures from a single task. Those measures,
however, are not enough to assess the whole motor control
system involved in reaching movements. On the other
hand, Coderre et al. [14] present another classification of
robotic measures based on motor control theory: postural
control, visual reaction, feed-forward control (initiation of
movement), feedback control (corrective responses), and
total movement metrics. This approach may be able to
reveal directly the underlying strategies of the motor
control system in reaching movements. We can obtain
these robotic measures from a task called Visually
Guided Reaching (VGR) among the standard tasks of
the KINARM Exoskeleton (BKIN Technologies Ltd,
Kingston, ON, Canada) [14, 15].
Although these new robot-derived measures can po-
tentially add a new dimension to existing rehabilitation
practice, they need to be sufficiently validated and re-
vealed to have clinical usefulness and importance before
being used in practice. As for the KINARM Exoskeleton,
the validity of discriminability between normal and
abnormal in stroke patients has been reported [14, 16].
However, the correlations between robotic measures and
clinical scales assessing impairments in the paretic arm
have yet to be examined. For clinical use, it is very
important to ascertain that the robotic measures can
successfully vary in accordance with the severity of the
paresis and to know what indices among various robotic
measures are well correlated with the degree of paresis.
It has also been reported that the VGR parameters were
correlated with the Purdue Pegboard (PPB) and the
Functional Independence Measure (FIM) [16]. However,
validation of the VGR parameters with clinical assess-
ments focused on arm function has not been well exam-
ined because the PPB was developed for the evaluation
of manipulative dexterity rather than reaching [17].
Moreover, FIM, an evaluation of ADLs, is influenced by
various factors such as the ability of the trunk and of the
unaffected side [18] as well as the severity of impairment
in the affected arm. Therefore, the VGR parameters de-
rived from the KINARM Exoskeleton remain to be vali-
dated with well-established clinical assessments mainly
focused on arm impairment and/or function.
In addition, one of the characteristics of this KINARM
Exoskeleton is that it provides full gravitational support
and permits arm movement only in the horizontal plane
with reduced degrees of freedom: only one degree of
freedom each in the shoulder and the elbow. Therefore,
tasks in the KINARM Exoskeleton might be easier to per-
form than real, three-dimension tasks under the gravity
for the patients with hemiparesis. This is an advantage of
this robotic device in that even severe hemiparetic patients
can be assessed. Furthermore, reduced degree of freedom
may reduce movement redundancy resulting in less com-
pensatory movements. Hence the movement on this
robotic device may reflect true impairments and may be
robust indices for the impairments. However, here raises
the questions about whether these parameters obtained
from the task performed in reduced degree of freedom
with gravitational supports can provide any useful infor-
mation about the real movement performed in the three-
dimension.
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The purpose of this study is to examine the clinical use-
fulness and the validity of the reaching task in KINARM
Exoskeleton in hemiparetic stroke patients. More specific-
ally, the aims of the study are (1) to explore which robotic
measures of reaching movements represent the deficits of
motor control in the arm and which measures are related
to the overall motor control regardless of the paresis, and
(2) to examine the correlation between robotic measures




Patients with a hemiparetic arm due to chronic stroke were
recruited among those hospitalized for HANDS (hybrid as-
sistive neuromuscular dynamic stimulation) therapy [19] at
the Department of Rehabilitation Medicine at Keio
University Hospital during the period from November
2012 to January 2015. Inclusion criteria were as follows:
more than 150 days since stroke onset, no clinically
obvious cognitive deficits, living independently, no pain
in the paretic upper extremities, ability to maintain the
sitting position with no difficulty, and sufficient range
of motion to perform tasks in KINARM. Patients were
excluded from the study if exercise of the upper limbs
was prohibited for medical reasons or if the paretic
hand could not be raised to the height of the nipples in
the sitting position because of severe hemiparesis.
Patients with foreign materials (pacemakers, shunts, or
clipping) or a history of epilepsy were also excluded.
The study protocol was approved by the institutional
ethics committee (#20120070) and registered at the
UMIN Clinical Trial Registry (UMIN000009269). All
participants gave informed consent according to the
Declaration of Helsinki. Characteristics of the partici-
pants are shown in Table 1.
Robotic assessment of the reaching task
The robotic assessment was performed using the KINARM
Exoskeleton. The device has one degree of freedom for
each joint (shoulder and elbow): elbow flexion/extension
and horizontal shoulder adduction/abduction. This device
permits free arm movement in the horizontal plane
involving flexion and extension of the shoulder and
elbow by providing weight support to the arms on the
metallic framework with plastic troughs. Visual feed-
back can be given on the virtual reality display just
above the plane of the arms. Participants were initially
seated in the KINARM Exoskeleton with their shoul-
ders abducted. Then the experimenter adjusted the
exoskeleton, which consisted of plastic arm troughs
for each arm segment (arm, forearm, and hand), so
that it fit comfortably and the arms were in the same
plane as the shoulder (80–90° abducted).
Participants performed the VGR (a reaching task), one of
the standard tasks in the KINARM Exoskeleton. The goal
of the task was to make unassisted reaching movements
quickly and accurately from a centrally located target (1.0-
cm radius) to one of eight peripheral targets (1.0-cm radius)
distributed uniformly on the circumference of a circle (with
10 cm from the center target to each peripheral target) by
moving the shoulder and the elbow. The position of the tip
of the index finger was tracked using a computerized
representation (a small white circle, 0.4 cm radius) as visual
feedback. To characterize performance, twelve movement
parameters based on motor control theory were calculated
from each trial. Details of the task and parameters used in
this study have been described by Coderre et al. [14]. The
parameters are presented in Table 2.
Clinical assessments
Participants were examined with the following clinical
instruments:
1. Fugl-Meyer Assessment (FMA) [3]
This is one of the most widely used quantitative measures
of motor impairment in stroke patients with high inter-
rater reliability [20, 21] and validity [22]. This measure
offers five domains (motor function, sensory function,
balance, joint range of motion, joint pain) to assess syn-
ergistic and voluntary movement after stroke in about
thirty minutes. A three-point ordinary scale is used to
assess movement (0 = unable; 1 = partial; 2 = performs
fully) in each item. In this study, we only used part A of
the upper limb section (shoulder/elbow/forearm) in the
motor function domain (FMA-UE(A)) for the analyses.
Since the FMA-UE(A) consists of eighteen test items, the
score ranges from 0 (worst) to 36 (best).
Table 1 Characteristics of the participants
Characteristic (N = 56)
Age, mean ± standard deviation (range) 49.4 ± 11.8 (18–78)
Sex, male/female 37/19
Type of disease Cerebral infarction 22
Cerebral hemorrhage 32
Subarachnoid hemorrhage 2
Days after the onset of hemiparesis, median (range) 548.5 (164–6456)
FMA-UE (A), median (range) 22 (5–35)
SIAS-KM, median (range) 3 (2–4)
MAS elbow, median (range) 1 (0–2)
[10, 19, 24, 3, 0, 0]a
WMFT_FAS, median (range) 35 (22–58)
FMA-UE(A) Part A of the Fugl-Meyer Assessment Upper Extremity, SIAS-KM
Knee-Mouth test of the Stroke Impairment Assessment Set MAS Modified
Ashworth Scale, WMFT-FAS Functional Ability Scale of the Wolf Motor
Function Test. aThe number of participants in each category of the MAS
[0, 1, 1+, 2, 3, 4]
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2. Stroke Impairment Assessment Set (SIAS) [23]
This evaluation tool was developed and is widely
used in Japan to assess various aspects of impairment
in hemiplegic patients, including motor function, tone,
sensory function, range of motion, pain, trunk func-
tion, visuospatial function, speech, and sound side
function [23]. Its reliability, validity, and responsive-
ness have been reported previously [23, 24]. In this
study, we used part of it for assessing motor function
of proximal upper extremities: the Knee-Mouth Test
(SIAS-KM). In the sitting position, the participant
repeated lifting the affected hand from the contralat-
eral knee to the mouth so that the affected-side shoul-
der was abducted to 90°. A five-point scale is used: 0
= no contraction of the biceps brachii; 1 = unable to
reach the level of the nipples; 2 = unable to touch the
mouth; 3 = able to repeat the task with severe or mod-
erate clumsiness; 4 = able to repeat the task with mild
clumsiness; 5 = able to repeat the task as smoothly as
on the unaffected side.
3. Modified Ashworth Scale (MAS) [25]
This is a widely used scale for the assessment of the spas-
ticity. Scoring is based on the resistance to passive stretch
throughout the range of motion (ROM) of a joint (0 = no
increase; 1 = slight increase at the end of the ROM; 1+ =
slight increase throughout less than half of ROM; 2 =
increase through most of ROM but easily moved; 3 =
increase, passive movement difficult; 4 = rigid). In this
study, we evaluated MAS in the elbow flexor muscles in
the affected arm. We treated 1+ as 2 in the analysis of this
study. Therefore, the score for analyses ranges from 0 to 5.
4. Wolf Motor Function Test (WMFT) [7]
This is a performance-based test that can evaluate
upper extremity function through timed single- or
multiple-joint motions and functional tasks with high
reliability and validity [7, 26]. Each task item is timed
and the amount of the time required to perform the
tasks can be used as a quantitative measure of the
WMFT (WMFT-time). Each item is also rated by the six-
point Functional Ability Scale (FAS) (0 = no use; 1 = an at-
tempt is made to use the arm; 2 = the arm does participate,
but requires assistance of an uninvolved extremity; 3 =
movement is performed slowly and/or with effort; 4 =
movement is close to normal but slightly slower or may
lack precision; 5 = normal) and the total score is considered
as a qualitative score of the WMFT (WMFT-FAS). We
Table 2 The parameters of the visually guided reaching task
Parameters Description
Upper-limb postural control
Posture Speed (m/s) The mean hand speed for 500 ms before peripheral target illumination, when the hand should be at rest.
Visual reaction
Reaction Time (s) The time between illumination of the peripheral target and the onset of movement.
No Reaction Time The number of trials for which movement to the destination target could not be detected.
Feed-forward control (initiation of movement)
Initial Direction Error (radian) The angular deviation between (a) a straight line from the hand position at movement onset to the
destination target and (b) a vector from the hand position at movement onset to the hand position after
the initial phase of movement.
Initial Distance Ratio The ratio of (a) the distance the hand traveled during the participants’ initial phase of movement to (b) the
distance the hand traveled between movement onset and offset.
Initial Speed Ratio The ratio of (a) the maximum hand speed during the participant’s initial phase of movement to (b) the
maximum hand speed during the trial.
Feed-back control (corrective responses)
Speed Maxima Count The number of maxima in hand speed velocity between movement onset and offset.
Min-Max Speed (m/s) The differences between local speed peaks and minima.
Total movement metrics
Movement Time (s) The total time elapsed from movement onset to offset.
Path Length Ratio The ratio of (a) the distance travelled by the hand between the movement onset and offset and (b) the
straight-line
distance between the starting and destination targets.
Max Speed (m/s) The maximum hand speed during the trial.
No Movement End The number of trials for which a stopping on the destination target was not detected.
“Initial phase of movement” denotes the time from movement onset to the time of the first speed minimum
“Movement offset” indicates the time at which the participant finished their movement to the destination target; if the destination target was not reached, then
movement offset is not calculated
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included seven out of the fifteen motion tasks that require
only the proximal function—not the finger function—for
the analyses of this study: (1) forearm to table (side); (2)
forearm to box (side); (3) extend elbow (to the side); (4)
extend elbow (to the side, with weight); (5) hand to table
(front); (6) hand to box (front); and (7) reach and retrieve
(front). The FAS score ranges from 0 (worst) to 35 (best).
Analysis
Differences and correlation of robotic measures between
the paretic arm and the non-paretic arm
To explore robotic measures which have the potential to
distinguish the paretic arm from the non-paretic arm,
VGR parameters in the paretic arm were compared with
those in the non-paretic arm with the Wilcoxon signed
rank test. The effect size (ES) of the Wilcoxon rank sum
test was calculated by dividing the Z-score by the square
root of the total number of participants: ES = Z/sqrt(N).
Then, to explore which robotic measures are related to
motor control regardless of paresis, correlations between
VGR parameters in the paretic arm and in the non-
paretic arm were also examined with Spearman’s correl-
ation coefficients.
Correlations between robotic measures and clinical
assessments
To investigate the relationship between robotic measures
and clinical assessments, correlations between the VGR
parameters and clinical scales were investigated with
Spearman’s rank correlation coefficients.
All statistical analyses were performed using STATA/SE
13.1 (StataCorp., Texas, USA). The strength of the correl-
ation coefficients was interpreted according to Guilford
[27]: 0.0–0.2 little if any; 0.2–0.4 weak; 0.4–0.7 moderate;
0.7–1.0 strong. Any p-values less than 0.05 were considered
statistically significant.
Results
Differences and correlation of robotic measures between
the paretic arm and the non-paretic arm
As shown in Table 3, eleven of the twelve parameters
obtained from the VGR task in the paretic arm were statis-
tically different from those in the non-paretic arm with
large effect sizes (|ES| = 0.76–0.87), with the exception of
Max Speed (ES = −0.42). Table 4 shows that 2 parameters
(Reaction Time and Max Speed) had nearly moderate cor-
relations with statistical significance between the paretic
arm and the non-paretic arm.
Correlations between robotic measures and clinical
assessments
As for WMFT, only 44.6 % (25 out of 56 participants)
could complete all seven tasks without any assistance.
Because performance time of a task assisted by the non-
paretic arm or by therapists (FAS score ≤ 2) could not be
treated as an exact quantitative evaluation, total perform-
ance time of all seven tasks was not considered to be suit-
able for analyses in this study. Instead, we adopted the
sum of performance time in four out of the seven tasks
(tasks 1, 2, 5, and 6) as WMFT-time, excluding tasks 3, 4,
and 7, with which about half of the participants needed
some assistance (see Fig. 1a). On the other hand, we could
obtain all of the twelve parameters in the VGR task from
87.5 % of the participants (49 out of 56 participants). Each
parameter could be obtained for nearly 90 % of partici-
pants (details are shown in Fig. 1b). Six participants failed
to reach the target throughout the trial (No Movement





Wilcoxon signed rank test
p-values Effect size
Posture Speed [×10−2 m/s] 0.58 (0.13−1.37) 0.35 (0.16−0.61) <0.001 0.79
Reaction Time [s] 0.47 (0.32−0.67) 0.33 (0.25−0.42) <0.001 0.87
No Reaction Time 5 (0–60) 0 (0–13) <0.001 0.76
Initial Direction Error [×10−2 rad] 25.07 (3.71−94.67) 4.70 (2.20−10.43) <0.001 0.87
Initial Distance Ratio 0.43 (0.15−0.89) 0.89 (0.54−1) <0.001 −0.87
Initial Speed Ratio 0.84 (0.59−1) 1 (0.93−1) <0.001 −0.85
Speed Maxima Count 4.36 (2.16−10) 2.38 (1.63−3.63) <0.001 0.85
Min Max Speed [×10−2 m/s] 4.50 (0.84−19.27) 1.37 (0.52−4.33) <0.001 0.86
Movement Time [s] 2.10 (1.02−3.67) 1.15 (0.82−1.62) <0.001 0.87
Path Length Ratio 1.83 (1.11−5.95) 1.12 (1.05−1.42) <0.001 0.86
Max Speed [×10−2 m/s] 19.29 (7.81−37.51) 22.45 (12.52−38.50) 0.003 −0.42
No Movement End 15 (0–63) 0 (0–13) <0.001 0.78
n = 49. The data of participants who failed to reach the target during the trial (No Movement End = 64) (n = 6) or lacked any of the twelve parameters (n = 1) were
excluded from data analysis
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End = 64) and one participant could not get nine out of
twelve parameters.
Table 5 shows the correlations among the clinical scales.
Correlations between clinical scales were generally moder-
ate except for a strong correlation between FMA-UE(A)
and WMFT-FAS (r = 0.72, p < 0.01). The MAS score had
relatively weak correlation with the other scales and is thus
considered to be focusing on somewhat different aspects,
namely muscle tone, from what the others can describe
(impairment and/or functional performance).
Table 6 summarizes correlations between VGR parame-
ters and clinical scales. FMA-UE(A) showed significant
correlation with ten of the twelve VGR parameters, among
which nine correlation coefficients were moderate (|r| =
0.40–0.60). The WMFT-FAS (|r| = 0.52–0.64) and SIAS-
KM (|r| = 0.42–0.49) also showed significant and moder-
ate correlations with eight of the twelve VGR parameters.
MAS in the elbow correlated significantly with eight
parameters and among them six were moderate (|r| =
0.44–0.48). The WMFT-time (tasks 1, 2, 5, and 6) was
significantly but relatively weakly correlated with eight
parameters (|r| = 0.34–0.47).
Discussion
In this study, we examined the validity and clinical use-
fulness of reaching tasks in the KINARM Exoskeleton.
Our findings indicate that the obtained measures have
not only concurrent validity against common clinical
scales, but also the possibility of providing more useful
evaluations in severe hemiparetic patients than using
conventional clinical scales.
To begin with, the comparison between the paretic and
non-paretic arms revealed that robotic parameters could
detect the presence of paresis very clearly in the assessed
population, which is in accordance with the results de-
scribed by Coderre et al. [14]. As a new point, we sought
common features in the parameters of both sides by exam-
ining correlations between them. Interestingly, the values
for the paretic arm and non-paretic arm had correlations in
two parameters (Reaction Time and Max Speed), indicating
that these parameters may detect factors other than paresis
that affect motor control of bilateral sides in post-stroke
patients.
With regard to the validity of robotic measures, we found
significant correlations between the VGR parameters and
clinically well-established scales that describe the severity of
paresis, the FMA and the SIAS. The validity of the robotic
measures derived from the KINARM Exoskeleton in terms
of discriminability of abnormal from normal in patients
with stroke has already been reported [14, 16]. However,
the correlations between these robotic measures and the
clinical scales for assessing impairments have not been well
explored. In this study, we showed significant and moderate
correlations between most of the robotic parameters and
the clinical measures (9 with the FMA, 8 with the SIAS),
and thus confirmed for the first time the concurrent validity
of using the KINARM Exoskeleton for the assessment of
the severity of paresis.
In addition, we found significant and moderate correla-
tions between the VGR parameters and a part of the
WMFT, which is a well-established clinical scale for asses-
sing arm function. As introduced in the Background
section, it has been reported that two clinical measures (the
PPB and the FIM) correlated with the robotic measures
[16]. However, correlations could be drawn by other
confounding factors such as the severity of whole brain
damage, because these measures do not directly reflect arm
functions. Our results could ascertain for the first time the
validity of the VGR parameters with clinical assessments
focused on arm functions.
Among the twelve parameters of the VGR task, correl-
ation coefficients with clinical assessments higher than 0.6
were seen in the indices of feed-forward control (Initial
Direction Error, Initial Distance Ratio, and Initial Speed
Ratio) and Movement Time as total movement metrics.
As a parameter for this initial movement phase, Zollo
et al. [28] proposed the aiming angle, defined as the angu-
lar difference between the initial target direction and the
direction of travel in the task with the InMotion2 Robot.
They found that aiming angle had a significant correlation
with the FMA score. Our study revealed that more aspects
of feed-forward control are impaired in hemiparetic arm
movement— error in direction, inadequate distance to the
target, and failure to attain peak velocity during the initial
phase of movement. As for Movement Time, several other
Table 4 Spearman’s rank correlation coefficients between





No Reaction Time 0.10
Initial Direction Error 0.20
Initial Distance Ratio 0.03
Initial Speed Ratio 0.07
Speed Maxima Count 0.09
Min Max Speed 0.24
Movement Time 0.21
Path Length Ratio 0.03
Max Speed 0.42a
No Movement End 0.00
ap < 0.01. n = 49
The data of participants who failed to reach the target during the trial (No
Movement End = 64) (n = 6) or lacked any of the twelve parameters (n = 1)
were excluded from data analysis
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Fig. 1 Number of participants with qualitative data from Wolf Motor Function Test and KINARM Exoskeleton. a The number of participants who
could perform each task without any assistance in the Wolf Motor Function Test (i.e., score of the Functional Ability Scale = 3, 4, or 5). b The
number of participants for whom each parameter in the Visually Guided Reaching task could be obtained. The maximum number of participants
(56 participants = 100 %) are shown by the dotted line in each figure. PS, Posture Speed; RT, Reaction Time; NRT, No Reaction Time; IDE, Initial
Direction Error; IDR, Initial Distance Ratio; ISR, Initial Speed Ratio; SMC, Speed Maxima Count; MMS, Min Max Speed; MT, Movement Time; PLR,
Path Length Ratio; MS, Max Speed; NEM, No Movement End
Table 5 Spearman’s rank correlation coefficients between clinical scales
FMA-UE(A) SIAS-KM MAS elbow WMFT-FAS (prox) WMFT-time (1, 2, 5, 6) c
FMA-UE(A) 1.00
SIAS-KM 0.57a 1.00
MAS elbow −0.53a −0.33b 1.00
WMFT-FAS (prox) 0.72a 0.66a −0.45a 1.00
WMFT-time (1, 2, 5, 6) c −0.48a −0.56a 0.29b −0.58a 1.00
ap < 0.01, bp < 0.05. cThe data of participants who required any assistance in performing tasks 1, 2, 5, or 6 were excluded (n = 2)
FMA-UE(A), Part A of the Fugl-Meyer Assessment Upper Extremity; SIAS-KM, Knee-Mouth test of Stroke Impairment Assessment Set; MAS, Modified Ashworth Scale;
WMFT-FAS (prox), total score of Functional Ability Scale in tasks 1–7 of the Wolf Motor Function Test; WMFT-time (1, 2, 5, 6), total performance time in tasks 1, 2, 5,
and 6 of the Wolf Motor Function Test
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robotic devices adopt this type of measure [29–31]. In the
KINARM Exoskeleton, this parameter can be used as a
clinically validated continuous scale because our results
were almost the same as those reported by Dukelow
et al. [16].
Our findings are also in agreement with Colombo et al.
[32] in that the number of peaks in the hand velocity pro-
file in the MEMOS robot, similar to the Speed Maxima
Count in the KINARM Exoskeleton, is correlated signifi-
cantly with several clinical measures. Therefore, it might
be a clinically useful scale regardless of the type of robotic
device. Those multiple speed peaks within one reaching
movement are caused by a sequence of small movements.
Krebs et al. [33] and Rohrer et al. [34] termed those small
movements ‘submovements,’ and a decrease in submove-
ments, which means improvement in smoothness, can be
considered as the result of a learned process rather than a
natural consequence of the neuromuscular system. Inter-
estingly, this parameter has been understood in two differ-
ent contexts: as a parameter of feedback control as in the
KINARM Exoskeleton and as a parameter of movement
smoothness, as in the MEMOS robot. Further studies are
needed to explore the meaning of this new clinical meas-
ure in practice and to investigate the underlying mecha-
nisms of the submovements.
As for the clinical usefulness of the robotic measures
compared to the conventional clinical scales, we point
out two important facts. Firstly, the correlation coefficients
between the eight VGR parameters and the FMA-UE(A)
(|r| = 0.52−0.60) were stronger than those between the
WMFT-time (tasks 1, 2, 5, and 6) and the FMA-UE(A)
(|r| = 0.48), which means that the VGR parameters were
more sensitive in reflecting the FMA scores than the
WMFT tasks (tasks 1, 2, 5, and 6). Secondly, as shown in
Fig. 1, we could obtain more quantitative data from robotic
tasks than from the WMFT. Hence it is suggested that this
robotic task may have the potential to assess motor impair-
ment quantitatively with better accuracy than the WMFT,
which is one of the conventional clinical quantitative scales
in use. More importantly, these facts allow rehabilitation
practitioners to make use of the measurements provided
by this type of a robot to quantify upper extremity func-
tions in post-stroke patients with severe hemiparesis who
are difficult to assess in detail with existing clinical tasks.
The results of this study show that the measures obtained
from the two-dimensional reaching task with reduced
degrees of freedom in the KINARM Exoskeleton and the
clinical scales in three dimensions have significant correla-
tions. It means that compensating for the effect of grav-
ity by supporting the limb and decreasing the degrees
of freedom of the joints allows clinically relevant evalu-
ation of hemiparetic patients. On the other hand, this
weight-supporting system may potentially fail to detect
certain aspects of impairment in the paretic arm. Rela-
tively low correlations between the robotic measures
and the SIAS-KM, which is examined by a single anti-
gravitational task, might support this hypothesis.
In this study, we investigated chronic post-stroke patients;
this differs from previous reports, which assessed patients
in the subacute phase. In addition, the MAS scores of our
participants were relatively higher compared to those of the
participants in Dukelow’s study [16]. As shown in Table 1,
nearly 50 % of our participants marked MAS scores of 1+
or 2. On the contrary, the MAS scores in around 80 % of
Table 6 Spearman’s rank correlation coefficients between clinical scales and parameters of the Visually Guided Reaching task
Parameters of VGR FMA-UE(A) SIAS-KM MAS elbow WMFT-FAS (prox) WMFT-time (1, 2, 5, 6)
Posture Speed −0.24 −0.04 0.03 −0.01 0.01
Reaction Time −0.32b −0.28 0.15 −0.20 0.19
No Reaction Time −0.54a −0.46a 0.27 −0.52a 0.37b
Initial Direction Error −0.60a −0.42a 0.46a −0.57a 0.42a
Initial Distance Ratio 0.58a 0.43a −0.47a 0.64a −0.47a
Initial Speed Ratio 0.57a 0.42a −0.47a 0.62a −0.44a
Speed Maxima Count −0.58a −0.45a 0.47a −0.59a 0.40a
Min Max Speed −0.40a −0.28 0.36b −0.24 0.08
Movement Time −0.52a −0.45a 0.44a −0.60a 0.40a
Path Length Ratio −0.54a −0.49a 0.48a −0.53a 0.34b
Max Speed −0.06 −0.09 −0.08 0.08 −0.14
No Movement End −0.58a −0.49a 0.37b −0.58a 0.40a
ap < 0.01, bp < 0.05
Underlined numbers are correlation coefficients higher than 0.40. n = 47. The data for participants who failed to reach the target during the trial (No Movement
End = 64) or lacked any of the twelve parameters (n = 7) or who required any assistance in performing tasks 1, 2, 5, or 6 (n = 2) were excluded from data analysis
FMA-UE(A) Part A of the Fugl-Meyer Assessment Upper Extremity, SIAS-KM Knee-Mouth test of Stroke Impairment Assessment Set, MAS Modified Ashworth Scale;
WMFT-FAS (prox) total score of Functional Ability Scale in task 1–7 of the Wolf Motor Function Test, WMFT-time (1, 2, 5, 6) total performance time in tasks 1, 2, 5,
and 6 of the Wolf Motor Function Test
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their participants were rated as 0 or 1 [16]. Despite these
differences, the robotic measures have significant correla-
tions with clinical scales assessing the severity of paresis or
reaching function of the arm. The results indicate that the
KINARM Exoskeleton can be used practically, even in the
chronic phase after a stroke with muscle spasticity.
On the other hand, correlation between the robotic
measures and the MAS score in the affected elbow
flexor muscles itself was relatively low. The MAS score
showed moderate correlation with some parameters of
feed-forward and feedback control, but not with two of
the measures (No Reaction Time and No Movement
End) which correlated more strongly with the other
clinical scales. Similarly, Bosecker et al. reported that
the MAS scores were poorly estimated by the linear re-
gression model developed from kinematic and kinetic
measures of the InMotion2 robot [29]. Therefore, the
MAS score, which represents muscle spasticity, may
have an effect on reaching movement in a different way
from that in which paresis affects motor control. Alter-
natively, poor correlations between the robotic mea-
sures and the MAS score may be due to the weight-
supported conditions of the robotic device, as clinicians
often observe that muscle tone is reduced in weight-
supported conditions. Further study is required to re-
veal the effect of muscle spasticity on motor control in
post-stroke patients.
This study has several limitations. Firstly, all partici-
pants enrolled in the study suffered from chronic stroke;
therefore, generalization of our results to acute or sub-
acute patients is unknown. Secondly, we had no control
participants to compare with the hemiparetic patients.
Another study design will be required to compare the
detectability of slight impairment between robotic and
conventional assessments. Thirdly, we did not obtain the
clinical scales from the non-paretic arm. Investigation
including the correlations between the clinical scores
and the VGR parameters in the non-paretic arms would
add more insight into the usability of robotic assess-
ments. Finally, the design of this study is cross-sectional.
A longitudinal design is needed to compare responsive-
ness between robotic and conventional assessments.
Conclusions
This study showed the clinical usefulness and validity of
robotic measures obtained from a reaching task in the
KINARM Exoskeleton. These measures not only provided
objective, quantitative, and continuous assessments of
hemiparetic arm movement, but also had stronger correl-
ation with measures of motor impairment than existing
quantitative scales of functional ability. Our findings in-
dicate that these robotic assessments through two-
dimensional tasks in the weight-supported condition
can provide clinically meaningful evaluations as well as
information about the mechanism of reaching move-
ment motor control in post-stroke patients. This is an
important step toward bringing robotic technologies
into the clinical rehabilitation setting.
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